SHMARQL

rosuvastatin

<http://www.wikidata.org/entity/Q415159>

chemical compound
rdfs:label
"rosuvastatin"@en
skos:altLabel
"(3R,5S,6E)-7-{4-(4-fluorophenyl)-6-(1-methylethyl)-2-[ethyl(methylsulfonyl)amino]-5-pyrimidinyl}-3,5-dihydroxy-6-heptenoic acid"@en
"(3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid"@en
"AZD4522"@en
"S-4522"@en
"ZD4522"@en
schema:description
"chemical compound"@en
schema:dateModified "2026-10-26T16:14:27+00:00"^^xsd:dateTime
schema:version 2561109402
wikibase:identifiers 38
wikibase:sitelinks 34
wikibase:statements 99
p:P10245 wd:statement/Q415159-5debd3c3-4f9f-ac6a-6d34-fcb24a3172bd
p:P10283 wd:statement/Q415159-3D575D6F-FF04-43B7-AE82-4B720D9F38FF
p:P11089 wd:statement/Q415159-1DA2A03C-2CB7-481E-BCEA-C6BACC1A2C44
p:P11143 wd:statement/Q415159-61B82F33-451C-454D-B803-2E1A9FD9DC2C
p:P11198 wd:statement/Q415159-E71EE148-C6C2-413E-A275-41ED955DF5AC
p:P11199 wd:statement/Q415159-F07249C9-BF4D-4F1A-95A8-25EC5E7C7E65
p:P117 wd:statement/Q415159-05B5EA6E-596B-4D03-82D9-632B1D682C0C
p:P129 wd:statement/Q415159-DBA4D2C7-88E5-4CE9-98F1-B556E14FC974
p:P15001 wd:statement/Q415159-8484b2b5-4514-05d3-2eef-6101a7cd2425
p:P1579 wd:statement/Q415159-C275FE2F-99E3-45E0-B064-6B7E69B38C3D
p:P1889 wd:statement/Q415159-2d609109-4b6a-45a9-2c9c-79bcca425853
p:P2017 wd:statement/Q415159-AF8EB556-3707-44E4-9E9F-EAA4E42B035F
p:P2057 wd:statement/Q415159-7B69089C-9383-45C6-9144-2051F3CA30C0
p:P2062 wd:statement/Q415159-94EE9D4E-CC4D-4CB7-AB1D-BCE9DFEDCB68
p:P2067 wd:statement/Q415159-079591C3-8467-4C68-8B16-488AC132FFE5
p:P2115 wd:statement/Q415159-69308952-762F-4509-BF28-821FD0FE5C2B
p:P2175 wd:statement/Q415159-06FA1ECA-7E17-4619-8C41-40BB65BF2F01
wd:statement/Q415159-1491AC1E-849A-4EA7-9F7C-397690AE85FF
wd:statement/Q415159-4ED1B51E-51F0-4A9B-9247-5E843B14B542
wd:statement/Q415159-649F39B0-5CF9-4C28-A40F-2DCC2F7EB15E
wd:statement/Q415159-6C47DCBD-5F99-4D21-8A0F-29B1224F7FF3
wd:statement/Q415159-AF4DC94E-1152-47B1-B02C-108375EA9038
wd:statement/Q415159-DBCC607F-BB03-4F01-9312-227EDCE2A932
p:P2275 wd:statement/Q415159-52429EAB-67E5-4F54-9BDE-12FB971ABE27
p:P231 wd:statement/Q415159-0184106C-498D-4FBE-B952-4F8F1918D743
p:P232 wd:statement/Q415159-A56C01E6-B7AE-40DE-B32E-466B1A816FFE
p:P233 wd:statement/Q415159-36188286-DFF9-4311-BD8F-04F382E9E469
p:P234 wd:statement/Q415159-BD6BFAED-FC5A-46DE-AA5A-E827A7CBD30C
p:P235 wd:statement/Q415159-FAC76F4F-C451-43D8-9764-6ABDE4B6AC88
p:P2566 wd:statement/Q415159-13572468-2468-1357-eca9-bdf024681357
p:P267 wd:statement/Q415159-9A4AE370-2717-4257-A7E6-A48C8E1BADD0
p:P274 wd:statement/Q415159-5ED974FC-125A-4FB8-AAA7-6C3F1D4D498F
p:P279 wd:statement/Q415159-42A74244-B4FA-4554-B0C5-73812E0ED285
wd:statement/Q415159-4dfc14ad-4583-a036-2b4f-fdfee12d72f7
p:P2868 wd:statement/Q415159-06D68A49-F7C3-4697-AE9D-B0235EC43808
p:P2877 wd:statement/Q415159-AA84D7CE-79B9-43B8-B81E-6DC99D4462C5
p:P2892 wd:statement/Q415159-A37628CF-D5E8-47FB-92C6-0ACACE1C1B32
p:P31 wd:statement/Q415159-52990140-8AEA-4EAD-9A6C-6AFAEDF5BC56
p:P3117 wd:statement/Q415159-5846119A-CD71-4586-8605-EB443DFE8523
p:P3345 wd:statement/Q415159-14A413ED-1F56-4FFF-B925-D04CEFA6BF2A
p:P3350 wd:statement/Q415159-c727c8d3-4d52-1bab-eb75-6b9eb676b947
p:P3364 wd:statement/Q415159-12D7BA76-484C-44E1-89BA-34A4B8663EE7
wd:statement/Q415159-2C94810B-AEA2-4F0A-952A-16C403873DEE
p:P3489 wd:statement/Q415159-56956F99-C56B-4F68-846B-F83CCBBF5102
wd:statement/Q415159-D1305D1C-E7B7-48DE-B879-FB7C6C5B00E8
p:P366 wd:statement/Q415159-04112263-E279-4AF3-9034-E6CF1CF4F407
p:P373 wd:statement/Q415159-1C73DD32-EE26-447C-BE9E-07944D7EDD8A
p:P3780 wd:statement/Q415159-84677224-1961-499A-B79E-8F830FEBB849
p:P4235 wd:statement/Q415159-65E0804C-EE37-4634-AEC7-12FB71F5A60B
p:P4250 wd:statement/Q415159-1C1F64F1-2AAC-4B1B-B7B3-0B64FA23D1BE
p:P4964 wd:statement/Q415159-5E830FC1-15F9-4BF6-A326-5A9BA84E01B4
p:P5008 wd:statement/Q415159-ACFD6DD8-82EA-4915-AA3B-B37DBEF97690
p:P527 wd:statement/Q415159-1287A519-8989-4CAE-8443-D911FE2D14F7
wd:statement/Q415159-7DF60FB1-4E53-4530-9D7A-E57A57F521A4
wd:statement/Q415159-7E55C4A4-5A84-4465-AEA9-FFB048B6326D
p:P592 wd:statement/Q415159-B46117B4-B6D3-4C7D-AA8F-B08C30717E69
p:P595 wd:statement/Q415159-1362EE83-9853-46AD-9E06-E77D5B749D66
p:P6366 wd:statement/Q415159-5622E26D-882E-4315-9717-1046FEC877E4
p:P646 wd:statement/Q415159-CBC2ED36-5066-439E-B29A-C8D35B86DAFD
p:P652 wd:statement/Q415159-DAD7A1D7-D61A-4C64-8BD3-7C1534C8E25A
p:P661 wd:statement/Q415159-45370E58-1F54-444C-BE5F-A0602613F93E
p:P662 wd:statement/Q415159-00AC0BDC-681F-4D79-8B27-20D73F4560DC
p:P665 wd:statement/Q415159-7D0A5725-40EF-4E84-8B76-7BB2AE1B6981
p:P6689 wd:statement/Q415159-238F98FE-30D1-4EC8-912B-799D47ADD97D
p:P6694 wd:statement/Q415159-A4619E0A-85A8-44AA-8522-CB5B065BC4AA
p:P683 wd:statement/Q415159-7628787C-EFCB-4E75-9009-B96CB5FFC09C
p:P715 wd:statement/Q415159-E42AA12C-7297-497B-9B81-9DA64908192A
p:P769 wd:statement/Q415159-09F6D2F8-E45A-48EB-9737-91CA11E69EC4
wd:statement/Q415159-116E563C-1F0F-4730-BD8E-33D318DC0A33
wd:statement/Q415159-1DF19F44-379F-4F18-A2E6-B7C51C099298
wd:statement/Q415159-25AC5388-6AC1-4EC5-8B19-B78C0C6B6A13
wd:statement/Q415159-29B29A2C-DF5D-4777-A6FB-666C19976A76
wd:statement/Q415159-2ECCDB73-457A-49FF-8636-F233078AEB51
wd:statement/Q415159-2FE5EAA1-E6CE-4BFF-BAFB-A7E685FB1BD1
wd:statement/Q415159-4CE50568-872B-4249-BB95-470794431AB2
wd:statement/Q415159-5C6B9101-E33D-4D6C-8CFC-99460BD8E808
wd:statement/Q415159-6AC7D202-4A88-4790-8C28-8785E29867CE
wd:statement/Q415159-6E82BAA7-499E-415C-9CB1-F0EC19C0F880
wd:statement/Q415159-78A793FA-AF64-4896-B673-769C311C75C6
wd:statement/Q415159-798D4E81-A379-48BE-B797-CD801311ABB1
wd:statement/Q415159-8132F7E0-A861-41ED-8824-A633D90F32C7
wd:statement/Q415159-87766B91-3599-4BF9-ABE5-9876C8F1A209
wd:statement/Q415159-9392D5D0-6579-407F-963D-394304012801
wd:statement/Q415159-9A76659D-C3D2-4001-9D76-7E7185A3137E
wd:statement/Q415159-A27E3FAE-FC8F-4B31-A711-D7682249E15D
wd:statement/Q415159-A841F1D5-AC2D-44D9-BF35-33F2F4F6F980
wd:statement/Q415159-A941D16A-6D07-4DA6-BEC4-505575B233E1
wd:statement/Q415159-B287680E-3CF3-4F18-BC4A-5E0274F464DB
wd:statement/Q415159-B4BCD9E2-3B65-4793-A9A2-34D735752906
wd:statement/Q415159-D558BE27-3852-4EAD-A800-376B51ED1268
wd:statement/Q415159-D75E0B33-7DD9-418F-B441-F1966335F384
wd:statement/Q415159-E873ACD0-DDF4-4B62-BD4A-F43AD574D159
wd:statement/Q415159-F8C214F9-9BF2-4F54-A0F0-57FFBB871ED0
wd:statement/Q415159-FDC80E44-64FC-4B78-B459-7486A5EB2420
wd:statement/Q415159-FFD4AFCE-4AFF-47BD-9383-089335551DAF
p:P7830 wd:statement/Q415159-C6A0C187-0316-4988-B928-FAE98F864E81
p:P8026 wd:statement/Q415159-5716A4D4-ECB4-46D8-AA1E-6D044EF345E1
p:P8072 wd:statement/Q415159-94E890F7-3B95-4ACE-AB56-79907FEA3E5E
p:P8494 wd:statement/Q415159-D65C4116-01D5-4282-83E1-CDD27C37F3C4
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148821>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1496>
p:direct-normalized/P6366 <https://makg.org/entity/2780499067>
p:direct-normalized/P661 <http://rdf.chemspider.com/393589>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157>
p:direct-normalized/P665 <http://www.kegg.jp/entry/D08492>
p:direct-normalized/P6694 <http://id.nlm.nih.gov/mesh/M0382713>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_38545>
wdt:P10245 "a603033"
wdt:P10283 "C2780499067"
wdt:P11089 "511938"
wdt:P11143 "Rosuvastatin"
wdt:P11198 "2406"
wdt:P11199 "PD009808"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Rosuvastatin%20structure.svg>
wdt:P129 3-hydroxy-3-methylglutaryl-CoA reductase
wdt:P15001 "AZD4522"
wdt:P1579 "9670765"
wdt:P1889 rosuvastatin calcium
wdt:P2017 "CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C"
wdt:P2057 "HMDB0015230"
wdt:P2062 "7317"
wdt:P2067 481.168285^^xsd:decimal
wdt:P2115 "N0000148821"
wdt:P2175 atherosclerosis
lipid metabolism disorder
lipedema
arteriosclerosis
heart disease
familial hypercholesterolemia
rare dyslipidemia
wdt:P2275 "rosuvastatin"@en
wdt:P231 "287714-41-4"
wdt:P232 "689-191-5"
wdt:P233 "CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C"
wdt:P234 "InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1"
wdt:P235 "BPRHUIZQVSMCRT-VEUZHWNKSA-N"
wdt:P2566 "100.216.011"
wdt:P267 "C10AA07"
wdt:P274 "C₂₂H₂₈FN₃O₆S"
wdt:P279 carboxylic acid
statin
wdt:P2868 statin
wdt:P2877 "2520"
wdt:P2892 "C0965129"
wdt:P31 type of chemical entity
wdt:P3117 "DTXSID8048492"
wdt:P3345 "301542"
wdt:P3350 "8021"
wdt:P3364 (3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-yl-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid
(E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
wdt:P3489 US pregnancy category X
Australian pregnancy category D
wdt:P366 medication
wdt:P373 "Rosuvastatin"
wdt:P3780 Crestor
wdt:P4235 "rosuvastatin"
wdt:P4250 10.0^^xsd:decimal
wdt:P4964 "splash10-014l-0029800000-3c828e60429014535277"
wdt:P5008 concrete/abstract disjunction anomalies
wdt:P527 carbon
nitrogen
oxygen
wdt:P592 "CHEMBL1496"
wdt:P595 "2954"
wdt:P6366 "2780499067"
wdt:P646 "/m/02z705"
wdt:P652 "413KH5ZJ73"
wdt:P661 "393589"
wdt:P662 "446157"
wdt:P665 "D08492"
wdt:P6689 "MSBNK-UPAO-UPA00013"
wdt:P6694 "M0382713"
wdt:P683 "38545"
wdt:P715 "DB01098"
wdt:P769 rac-warfarin
fosamprenavir
ledipasvir
acenocoumarol
(S)-(−)-colchicine
ciprofibrate
cyclosporine
gemfibrozil
(2R)-daptomycin
fenofibrate
lopinavir
ritonavir
saquinavir
atazanavir
bezafibrate
wdt:P7830 "Rosuvastatin"
wdt:P8026 LiverTox toxicity likelihood category B
wdt:P8072 "262259"
wdt:P8494 "DTXCID90820057"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata